BFC Planning’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
SL
BFC Planning's TNGX Position: Q3 2026 in Review
BFC Planning opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 20 shares worth $499. The stake represents ﹤0.01% of the portfolio and ranks #3287 among its holdings.
161 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.
- BFC Planning held 20 shares of Tango Therapeutics worth $499 as of Q3 2026.
- Tango Therapeutics was a new BFC Planning position in Q3 2026.
- Tango Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3287 holding.
- 161 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.